awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28445037-DCEB5ED8-B65C-48CC-A3AB-3A49736E88D9
Q28445037-DCEB5ED8-B65C-48CC-A3AB-3A49736E88D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28445037-DCEB5ED8-B65C-48CC-A3AB-3A49736E88D9
KRAS MUTATION
P3354
Q28445037-DCEB5ED8-B65C-48CC-A3AB-3A49736E88D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28445037-DCEB5ED8-B65C-48CC-A3AB-3A49736E88D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
957f7f8b29d76155739efa0fcfebb4b84ce30c5d
P1310
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.
P2175
non-small-cell lung carcinoma
P4271
CIViC 4-star trust rating
P459
CIViC evidence level B
P3354
docetaxel trihydrate